4.6 Article

Crosstalk Between c-Myc and Ribosome in Ribosomal Biogenesis and Cancer

Journal

JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 105, Issue 3, Pages 670-677

Publisher

WILEY
DOI: 10.1002/jcb.21895

Keywords

c-Myc; RIBOSOMAL BIOGENESIS; RIBOSOMAL PROTEINS; L11; TRANSCRIPTION; CELL CYCLE

Funding

  1. National Cancer Institute (NCI) [CA93614, CA095441, CA 129828]
  2. NCI [K99-CA127134]
  3. Indiana University Biomedical Research Grant

Ask authors/readers for more resources

Protein production is driven by protein translation and relies on ribosomal biogenesis, globally essential for cell growth, proliferation, and animal development. Deregulation of these sophisticated Cellular processes leads to abnormal homeostasis and carcinogenesis. Thus, their tight regulation is vitally important for a cell to warrant normal growth and proliferation. One newly identified key regulator for ribosomal biogenesis and translation is the oncoprotein c-Myc, whose aberrantly excessive level and activity are highly associated with human cancers, too. Recently, we have shown that ribosomal protein L11 functions as a feedback regulator of c-Myc. Hence, in this review, we will provide some prospects on the interplay between c-Myc and ribosomal proteins during ribosomal biogenesis and discuss its implications in cancer. J. Cell. Biochem. 105: 670-677, 2008. (c) 2008 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available